Search results
Sep 13, 2024 · Keith Holliday, PhD Chief Technology Officer. Dr. Keith Holliday joined STAAR in August 2015 as Vice President of Research and Development. In March 2017, he assumed the role of the Chief Technology Officer.
Sep 23, 2024 · STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, has named Keith Holliday Ph.D. to the position of Vice President, Research and Development, effective August 19 , 2015.
6 days ago · Laya DeLeon Hayes , Denzel Whitaker , Chad Coleman, Reilly Brooke Stith , Keith Sean Holliday , Amani Summer Boyles Runtime 91 Minutes
5 days ago · STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye.
Sep 24, 2024 · STAAR Surgical has 5 employees across 5 locations and $322.42 m in annual revenue in FY 2023. See insights on STAAR Surgical including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
Sep 19, 2024 · Greensboro Mayor Keith Holliday meets with the Greensboro delegation of legislators Rep. Alma S. Adams-D. Guilford, Senator Katie Dorsett-D. Guilford and Rep. Maggie Jeffus-D. Guilford after a...
5 days ago · The following insiders have sold STAA shares in the last 24 months: James E Francese ($2,656,875.00), and Keith Holliday ($51,001.31).
